where to buy ipamorelin cjc 1295 CJC-1295 + CJC-1295 Without DAC / Ipamorelin

Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL = ~1.67 mg/mL) Frequency: Inject once daily subcutaneously

It holds an FDA approval from 2010 and has been examined in multiple randomized controlled trials for visceral adipose tissue in adults with HIV-associated lipodystrophy

The foundational science is covered in our earlier physicians guide to peptide therapy

In a 12-week randomized clinical trial involving 300 obese adults, participants receiving 1 mg daily of AOD-9604 lost an average of 2.6 kg (approximately 5.7 pounds) compared to 0.8 kg (1.8 pounds) in the placebo group

CJC-1295 (no DAC) activates GHRH receptors (GHRH-R) on pituitary somatotrophs, while ipamorelin activates Growth Hormone Secretagogue Receptor 1a (GHSR-1a)